Eli Lilly’s ZEPBOUND (tirzepatide) has received FDA approval to treat adults with diabetes mellitus type 2, significantly expanding the company’s domi...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Zydus Lifesciences Limited received FDA approval for its combination tablet of sitagliptin and metformin hydrochloride, a move aimed at broadening acc...
Nuvaila Limited announced the 2023 FDA approval of WEZLANA, an intravenous ustekekinumab-auub, positioning the manufacturer to leverage significant ma...
NorthStar RxLLC announced on October 20, 2023, that the FDA has granted approval for its Oxcarbazepine tablet, ANDA 216749, offering a potential high-...
UCB, Inc. announced on Thursday that the FDA granted accelerated approval to its novel antiphospholipid syndrome drug ZILBRYSQ (zilucoplan), signaling...
# FDA Approves Novartis's Cosentyx (Secukinumab) Intravenous Formulation Novartis Pharmaceuticals Corporation received FDA approval for an intravenou...
Laurus Labs Limited received FDA approval on October 5, 2023, for its generic product under application number ANDA217631, signaling a significant exp...
On September 29, Marksans Pharma Limited received approval from the FDA for its ANDA217264 to market Esomeprazole Magnesium Delayed-Release Capsules, ...
Pfizer secured the FDA's approval of BOSULIF (bosutinib) on September 26, a regulatory win expected to bolster the pharmaceutical giant's oncology rev...
On September 25, Oyster Point Pharma announced FDA approval of RYZUMVI (phentolamine mesylate) ophthalmic solution for the treatment of surgically ind...
GlaxoSmithKline plc has secured regulatory approval from the FDA for Momelotinib Dihydrochloride Monohydrate (NDA216873), a novel oral therapy aiming ...
# FDA Approves Gamida Cell's APHEXDA for Hematopoietic Stem Cell Mobilization Gamida Cell Inc. received FDA approval for APHEXDA (motixafortide aceta...
# FDA Approves Fresenius Kabi's Generic Gadobutrol, Expanding MRI Contrast Agent Competition Fresenius Kabi USA, LLC has received FDA approval for it...
# FDA Approves Heritage Pharmaceuticals' Generic Mycophenolate Mofetil Heritage Pharmaceuticals Inc. (operating as Avet Pharmaceuticals Inc.) has rec...
# FDA Approves Generic Version of Lisdexamfetamine Dimesylate Camber Pharmaceuticals, Inc. received FDA approval for its generic formulation of lisde...
Alembic Pharmaceuticals Limited secured FDA approval for its generic Brimonidine Tartrate and Timolol Maleate ophthalmic solution, allowing the compan...
Camber Pharmaceuticals, Inc. announced the approval of its Abbreviated New Drug Application for lisdexamphetamine dimesylate, a strategic development ...
Solco Healthcare US, LLC has received FDA approval for the oral lisdexamphetamine dimesylate capsules (ANDA 216266), paving the way for the anticipate...
Lannett Company announced the FDA approval of its lisdexexamfetamine dimesylate generic this week, with market analysts suggesting the move will deepe...
# FDA Approves Steriscience Specialties' FOCINVEZ, Expanding IV Antiemetic Options in Competitive Market Steriscience Specialties Private Limited rec...